HUTCHMED (China) Limited Profit Margin

The latest profit margin for HCM is 83.3% as of December 2025. That compares with -3.34% in the prior-year period — up 2590.5% year over year. That is above the Healthcare sector average of 15.58%. Investors often review this figure alongside HUTCHMED (China) Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, HCM's profit margin moved from -3.34% to 83.3% — a 2590.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HUTCHMED (China) Limited's valuation or profitability profile.

Against Healthcare companies, HCM currently prints 83.3% for profit margin, while the sector average sits near 15.58%. That is roughly 434.5% above the sector mean. Large gaps often invite a closer look at HUTCHMED (China) Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively HUTCHMED (China) Limited converts resources into returns. At 83.3%, HCM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -3.34% in the prior-year period — up 2590.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HCM's profit margin (83.3%), review year-over-year change from -3.34%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.